However, in contrast to other malignancies, ccRCC displays reduced fatty acid oxidation, which is primarily attributed to the inhibition of carnitine palmitoyltransferase 1A (CPT1A), the key enzyme for fatty acid oxidation (20). The gene discussed is CPT1A; the disease is nonpapillary renal cell carcinoma.